Last reviewed · How we verify
Lactosa (placebo arm) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Lactosa (placebo arm) (Lactosa (placebo arm)) — Fundació Sant Joan de Déu. Lactose is an inert sugar used as a placebo control in clinical trials and has no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lactosa (placebo arm) TARGET | Lactosa (placebo arm) | Fundació Sant Joan de Déu | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lactosa (placebo arm) CI watch — RSS
- Lactosa (placebo arm) CI watch — Atom
- Lactosa (placebo arm) CI watch — JSON
- Lactosa (placebo arm) alone — RSS
Cite this brief
Drug Landscape (2026). Lactosa (placebo arm) — Competitive Intelligence Brief. https://druglandscape.com/ci/lactosa-placebo-arm. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab